Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5160991 | 0.91 | CYP1A2 (0.39) | CYP1A2CYP3A4CYP2C19KDM4EALDH1A1 | |
| SCHEMBL5159277 | 0.89 | CYP1A2 (0.40) | CYP1A2CYP3A4CYP2C19KDM4EALDH1A1 | |
| SCHEMBL5156290 | 0.87 | P2RX3 (0.32) | — | |
| SCHEMBL6671259 | 0.81 | CYP1A2 (0.35) | CYP1A2CYP3A4CYP2C19KDM4E | |
| SCHEMBL5158190 | 0.81 | NPSR1 (0.33) | ALDH1A1TP53NPSR1 | |
| SCHEMBL5158887 | 0.78 | — | — | |
| SCHEMBL5161150 | 0.77 | CYP2C19 (0.37) | CYP1A2CYP3A4CYP2C19KDM4EALDH1A1 | |
| SCHEMBL5158793 | 0.77 | — | — | |
| SCHEMBL5363317 | 0.77 | CYP1A2 (0.36) | CYP1A2CYP3A4CYP2C19KDM4EALDH1A1 | |
| SCHEMBL4616407 | 0.77 | L3MBTL1 (0.34) | ALDH1A1NPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070135468-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-06-14 | — | — | US | disclosed |
| EP-1456174-B1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | SYNGENTA LTD (GB) | 2007-02-14 | — | — | EP | disclosed |
| US-7166621-B2 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | SYNGENTA LIMITED (GB) | 2007-01-23 | — | — | US | disclosed |
| US-20050065032-A1 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-24 | — | — | US | disclosed |
| EP-1456174-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | Syngenta Limited (GB) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003048128-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2003-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065032-A1 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | DDT, C3AR1, CNPY3 | CYP1A2 334/4885CYP3A4 316/4885CYP2C19 842/4885 |
| US-20070135468-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | DDT, C3AR1, CBR3 | CYP1A2 216/4885CYP3A4 250/4885CYP2C19 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.